Global Stress Urinary Incontinence Market - 2022-2029

Market Overview

Stress Urinary Incontinence Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 6.91 % during the forecast period (2022-2029).

Stress Urinary Incontinence (SUI) occurs when urine leaks out with sudden pressure on the bladder and urethra, causing the sphincter muscles to open briefly. With mild SUI, the pressure may come from sudden, forceful activity, such as exercise, sneezing, laughing, or coughing. Stress urinary incontinence is more severe and can leak with less vigorous activities such as standing up, walking, or bending over. Urinary accidents range from a few drops of urine, which is soaked in clothes. SUI is a common bladder problem for women. It happens less frequently in men. The major factors propelling the growth of the stress urinary incontinence market are the rising geriatric population across the globe and the increase in chronic diseases across the globe. Moreover, the Rise in the prevalence of urinary incontinence is the major factor expected to deliver significant growth to the market in the upcoming period.

Market Dynamics: Rising geriatric population worldwide drives market growth

Urinary incontinence means that a person leaks urine by accident. Although it may happen to anyone, urinary incontinence is more common in older people, particularly older women. Incontinence can often be healed or controlled. With the growing age, problems such as weak bladder muscles, pelvic floor muscles and others occur in an older population, hence, stimulating the causes of urinary incontinence. As per the World Health Organization report published in 2021, by 2030, 1 in 6 people in the world will be aged 60years or over. At that timeshare, the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2050, and the world's populations of people aged 60 years and older will double (2.1 billion). Thus, increasing incontinence in the elderly population is the major factor stimulating market growth over the forecast years.

However, a Lack of awareness among the incontinent patient population hampers the market growth. The lack of awareness among the incontinent patient population may reduce revenue growth in the stress urinary incontinence market. In addition, side effects such as urinary and faecal incontinence, pain, and organ perforation associated with female urinary incontinence devices deter revenue growth in the stress urinary incontinence market.

Market Segmentation: The internal vaginal device segment is projected to be the dominant segment in the market during the forecast period.

Based on the device type, the stress urinary incontinence market has been classified into internal urethral devices, internal vaginal devices and external urethral devices.

The internal vaginal devices segment can be further categorized into traditional and custom-made devices. Urinary stress incontinence is significantly more common in women than in men. Stress Urinary Incontinence occurs when pelvic floor muscles or urinary sphincter are likely to lose strength, either due to women's childbirth or men's prostate surgery. Thus, due to such factors, the internal vaginal device is expected to hold a dominant position in the market.

The stress urinary incontinence is segmented based on end-user, which includes hospitals, specialty clinics, and ambulatory surgical centers.

Hospital in the end-user segment is expected to have a significant share of the global market for urinary incontinence devices due to the large patient population treated in hospitals suffering from urinary incontinence. Moreover, Hospitals are also expected to grow with the highest CAGR in the forthcoming period with the rise in technological advancement in the industry.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the stress urinary incontinence market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America will be dominant in the global stress urinary incontinence market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. In the U.S., stress urinary incontinence is expected to have potential growth due to its well-developed health care infrastructure and high awareness of the latest medical developments among the people. Moreover, Latin America is expected to represent significant growth in terms of value during the forecast period. Factors such as the rise in chronic diseases are expected to propel regional market growth.

The stress urinary incontinence market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the rise in geriatric population & rising healthcare infrastructure in the region.

Competitive Landscape:

The stress urinary incontinence market is highly competitive, owing to the presence of big food brands. The key Stress Urinary Incontinence players which are contributing to the growth of the global market include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc, among others. The major players are adopting new product launches and expansion strategies for global growth in the stress urinary incontinence market. Some key players follow merger and collaboration strategies to expand their business. For instance, in January 2022, Coloplast A/S completed the acquisition of Atos Medical. This acquisition helps to grow the organic revenue of Coloplast by around 7 % at a constant exchange rate. With this acquisition, the company added a new business segment, ENT & Respiratory Care which is run as a separate strategic unit operating on shared Coloplast infrastructure in their portfolio. In November 2020, Coloplast, a danish medical device company, acquired Nine Continents Medical, Inc., an early-stage company pioneering an implantable tibial nerve stimulation treatment for overactive bladder, for USD 145 million. Nine Continents Medical, Inc. develops innovative solutions for the overactive bladder. This acquisition price includes an upfront cash payment and an additional contingent future milestone payment.

COVID-19 Impact: Negative impact on the global stress urinary incontinence market.

The outbreak of COVID-19 has negatively impacted the growth of the stress urinary incontinence market globally. Restrictions on hospital services have affected the specialized investigation and surgical management of patients with urinary incontinence. Doctors and hospital staff is busy in treated Covid patients. Patients with urinary incontinence avoid visits to hospitals and buy devices to avoid contamination. Therefore, the COVID-19 pandemic has hampered the market value of the stress urinary incontinence market in 2020.

The global stress urinary incontinence market report would provide an access to approximately 61 market data tables, 51 figures and 170 pages.